GILDER GAGNON HOWE & CO LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,347,000
-25.5%
179,090
-0.5%
0.02%
-25.0%
Q2 2022$1,809,000
-26.2%
179,966
-9.1%
0.03%
+39.1%
Q1 2022$2,450,000
-45.1%
197,935
+1.4%
0.02%
-8.0%
Q4 2021$4,466,000
+5.5%
195,283
+2.1%
0.02%
+13.6%
Q3 2021$4,234,000
+71.4%
191,314
+0.4%
0.02%
+83.3%
Q2 2021$2,470,000
+2.9%
190,565
+3.1%
0.01%
-7.7%
Q1 2021$2,400,000
-3.7%
184,825
+2.5%
0.01%
+8.3%
Q4 2020$2,493,000180,2500.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders